Gene expression in diabetic nephropathy

Curr Diab Rep. 2004 Dec;4(6):462-9. doi: 10.1007/s11892-004-0057-x.


Diabetic nephropathy (DN) is a common complication of diabetes types 1 and 2. One of the hallmarks of DN is the development of mesangial expansion, which occurs through accumulation of extracellular matrix (ECM) components. Altered local gene expression of humoral factors (eg, transforming growth factor-b, connective tissue growth factor, and platelet-derived growth factor) can lead to increased production of ECM components (eg, fibronectin and collagen IV) or decreased degradation through matrix metalloproteinases (eg, MMP-1, MMP-2). In recent years, new techniques for examination of gene expression have been developed. Because of their large scale and high-throughput character, it is now possible to examine differential gene expression in a large number of samples. This paper provides an overview of techniques used and results obtained in studies of DN. Newly developed concepts of how altered gene expression may affect histomorphologic features or clinical symptoms are also discussed.

Publication types

  • Review

MeSH terms

  • Diabetic Nephropathies / genetics*
  • Extracellular Matrix Proteins / genetics
  • Gene Expression Regulation*
  • Humans
  • Oligonucleotide Array Sequence Analysis / methods
  • Polymerase Chain Reaction / methods


  • Extracellular Matrix Proteins